Your session is about to expire
← Back to Search
Cannabinoid
Half strength Hemp Oil Preparation for Male Pattern Baldness (Hair Regrowth Trial)
Phase < 1
Waitlist Available
Led By Gregory L Smith, MD
Research Sponsored by Gregory L Smith, MD, MPH
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six months
Awards & highlights
Summary
This is a case series of adult, male and female subjects with androgenetic alopecia (male pattern baldness). A topical hemp oil that is rich in varins (THCV and CBDV) and cannabidiol (CBD) is being used daily for six months to stimulate hair regrowth using Endocannabinoid System (ECS) receptors that are found on hair follicles.
Eligible Conditions
- Male Pattern Baldness
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ six months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in nonvellus hair count in 1cm2 area of the bald scalp
Trial Design
2Treatment groups
Active Control
Group I: Half strength Hemp Oil PreparationActive Control1 Intervention
The topical preparation contains only 500mg of cannabinoids per ounce. The other ingredients are the same in both arms.
Group II: Full strength Hemp Oil PreparationActive Control1 Intervention
The topical preparation contains 1000mg of cannabinoids per ounce. The other ingredients are the same in both arms.
Find a Location
Who is running the clinical trial?
Gregory L Smith, MD, MPHLead Sponsor
Gregory L Smith, MD4.144 ReviewsPrincipal Investigator - Medical Life Care Planners, LLC
Medical School - Emory University, Doctor of Medicine
1 Previous Clinical Trials
25 Total Patients Enrolled
5Patient Review
I was very pleased with my visit. The staff was professional and I didn't have to wait long to see the doctor.
Share this study with friends
Copy Link
Messenger